Source: Lab Bulletin

Bruker: Bruker Announces Broad Infectious Disease Assay Portfolio on BeGenius Molecular Diagnostics Sample-to-Answer System

At the ESCMID Global conference, Bruker announced a significant menu expansion of its validated PCR assays on its BeGenius® sample-to-answer molecular diagnostics system, as well as automated sample preparation improvements for near-universal microbial identification by the MALDI Biotyper® platform, and new easy-to-follow IR Tracker software for push-button microbial strain typing by the IR Biotyper® system.

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Frank H Laukien's photo - Chairman & CEO of Bruker

Chairman & CEO

Frank H Laukien

CEO Approval Rating

74/100

Read more